Human Papiloma Virus
In Colombia, a bill that would introduce the vaccine into Bogotá's public health care system has just failed for the third time.
. . . . .
Abortion has no effect on long-term mental health; Clinton's likely priorities as Secretary of State; allergic reactions to Gardasil uncommon; what effect would HHS conscience regulations have?
. . . . .
Prof. Herald zur Hausen's Nobel Prize-winning research paved the way for the first vaccine against cancer in medical history, the HPV vaccine.
. . . . .
German virologist Harold zur Hausen’s Nobel Prize is a reminder that there is overwhelming scientific consensus that HPV is the cause of cervical cancer.
. . . . .
A majority of Colombian women get Pap smears, but new studies show that ten percent of such tests administered in Colombia yield inaccurate results.
. . . . .
By Alexa Stanard, New Journalist Fellow February 25, 2008 - 9:46am
A new study has found that administering the HPV vaccine based on a woman's risk factors could prevent access for the vast majority of eligible women. The study supports a federal recommendation that all females ages 11 to 26 should get the vaccine.
. . . . .
|
